A 50-Year-Old Woman with Recurrent Generalised Seizures by Ma, Ronald C. W et al.
PLoS Medicine  |  www.plosmedicine.org 1343 September 2008  |  Volume 5  |  Issue 9  |  e186
Learning Forum
DESCRIPTION OF CASE
A
50-year-old woman presented in May 2006 with 
recurrent generalised convulsions. She had a history 
of hypertension treated with indapamide, but was 
otherwise well. Her older sister and mother were known to 
have thyroid disease. She did not have any history of chronic 
alcohol use nor any recent history of head injury. The patient 
had never lived outside of Hong Kong. Prior to admission, 
she was taken to her general practitioner by her family for 
gradual onset of decreased alertness, cognitive decline, and 
reduced verbal communication, which worsened over the 
course of one week. She was found to have hypothyroidism 
with TSH (thyroid stimulating hormone) 52.3 mIU/l (normal 
range 0.47–4.68 mIU/l) and free T44.2 pmol/l (normal range 
10.0–28.2 pmol/l), and was started on thyroxine replacement. 
Four days later, she developed two generalised seizures 
within three days and was admitted into hospital. She was 
afebrile and had no focal neurological signs on examination. 
Baseline investigations, including electrolytes, liver function 
tests, calcium, and phosphate, were normal. Random plasma 
glucose was 5.7 mmol/l. Magnetic resonance imaging (MRI) 
of brain was unremarkable. She was subsequently transferred 
to our hospital for further management.
On admission, she was afebrile and had a series of 
seizures over a period of five hours without regaining full 
consciousness in between seizures. The patient was given 
intravenous diazepam and phenytoin, and was intubated and 
transferred to the intensive care unit. 
What Was Our Differential Diagnosis at This Stage? 
The patient presented with several days’ history of decreased 
consciousness, followed by acute symptomatic seizures. 
The differential diagnosis of someone with a subacute 
encephalopathy is wide, and possible causes are listed in 
Box 1. These include metabolic derangements such as 
hyponatraemia, as well as infections, central nervous system 
(CNS) disorders, drugs and toxins, systemic conditions such 
as hepatic encephalopathy, and psychiatric conditions. The 
patient was at risk of hyponatraemia in view of her use of 
indapamide, but her serum electrolytes were normal. She 
was afebrile and had no neck stiffness, though CNS infection 
would still need to be excluded. There was no known history 
of neurological or psychiatric conditions, though this would 
not preclude her from suffering from such conditions. 
Although there was no easily identifiable drug or toxic cause, 
these remained distinct possibilities and a toxicology screen 
was indicated.
What Was the Most Likely Diagnosis?
Although the patient had been diagnosed with 
hypothyroidism shortly prior to her presentation, the 
abnormal thyroid function tests could not fully explain her 
neurological state. Repeat serum electrolytes, liver function 
tests, and calcium and magnesium levels were all normal. 
Repeat TSH was 11 mIU/l. Computed tomography (CT) 
of the brain on admission was normal. A lumbar puncture 
was performed, which showed raised cerebrospinal fluid 
(CSF) protein 1.5 g/l. The paired CSF–plasma glucose 
levels were 7.0 mmol/l and 7.1 mmol/l. The CSF cell 
count, microscopy, and Ziehl-Neelson stain were all 
normal. The opening pressure was 13 cmH20. Polymerase 
chain reaction of the CSF was later found to be negative 
for herpes simplex, enterovirus, and varicella zoster 
virus DNA. Toxicology screen was negative. Her clinical 
seizures persisted, and intravenous infusion of propofol/
thiopentone was commenced. Over the subsequent 
four days, upon withdrawal of propofol and thiopental, 
the patient still demonstrated altered mental state. The 
electroencephalogram (EEG) monitoring showed repetitive 
focal spikes or sharps of less than three per second, which 
may be abolished by combination anti-epileptic therapy with 
phenytoin and sodium valproate, pointing towards non-
convulsive status epilepticus (Figures 1 and 2). 
Some conditions associated with multiple seizures are listed 
in Box 2. Structural brain lesions were not likely in our case, 
given the initial normal MRI imaging. Nevertheless, repeat 
imaging was warranted if the patient’s condition continued 
to deteriorate. Repeat CT brain performed three days after 
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admission was normal. Results of our investigations did not 
support metabolic or toxic causes. Sporadic Creutzfeldt-Jakob 
disease (CJD) can present with a similar clinical picture 
including dementia, myoclonus, ataxia, personality change, 
psychotic phenomenon, or even recurrent seizures [1,2] . 
However, the EEG of our patient did not reveal the periodic 
sharp wave complexes typical of CJD. Detection of the 14-3-3 
protein in the CSF would also support a diagnosis of CJD, 
though this test was not available in our hospital. Once 
infectious causes were excluded, other causes of a subacute 
encephalopathy, such as an autoimmune or inflammatory 
process, including paraneoplastic encephalitis, need to be 
considered.
What Tests Would Now Be Helpful?
As there was no other organic pathology to explain her 
recurrent seizures and subacute encephalopathy, a diagnosis 
of Hashimoto encephalopathy was considered in view of the 
recent diagnosis of hypothyroidism. Anti-microsomal and anti-
thyroglobulin antibodies titres were 1 in 25,600 and 1 in 400 
respectively, supporting a diagnosis of autoimmune thyroid 
disease. Anti-nuclear antibodies, anti-DNA, anti-extractable 
nuclear antigen, and anti-cardiolipin antibodies were all 
negative. The patient’s erythrocyte sedimentation rate and 
C-reactive protein were mildly elevated at 41 mm/h (normal 
<20 mm/h) and 39.5 mg/l (normal <9.9 mg/l), respectively, 
with complement C3 of 0.84 g/l (normal range 0.62–1.87 g/l) 
and C4 of 0.18 g/l (normal range 0.20–0.59 g/l).
What Was the Next Step in Her Management?
The patient was started on a trial of intravenous 
hydrocortisone 400 mg/day. Her neurological condition 
gradually stabilised, and a repeat EEG ten days after 
admission showed normal background with occasional 
interictal activities consisting of frontal predominant 
sharpish discharges. She was eventually taken off 
glucocorticoids after 18 days. The patient was fully orientated 
and able to walk unaided when discharged from hospital 
five weeks after admission, on maintenance phenytoin and 
valproate. 
Progress
Six months after discharge, her anti-microsomal antibodies 
titre was reduced to 1 in 6,400, and anti-thyroglobulin 
antibodies were undetectable. She remained seizure-free 
six months after discharge, and the anti-convulsants were 
gradually tapered off. When last seen in January 2008, she 
was well and biochemically euthyroid on thyroxine 0.1 mg 
daily and had not had any further seizures. She gave written 
consent for this case to be published.
A. Metabolic derangements
sÈ%LECTROLYTEÈDISTURBANCES
° Hyponatraemia or hypernatraemia
° Hypocalcaemia or hypercalcaemia
° Hypomagnesaemia or hypermagnesaemia
° Hypophosphataemia or hyperphosphataemia
sÈ%NDOCRINEÈDISTURBANCES
° Hypothyroidism (rarely thyrotoxicosis)
° Hyperparathyroidism or hypoparathyroidism
° Insulinoma
° Pituitary insufficiency
° Adrenal insufficiency or Cushing’s syndrome
sÈ(YPOXIA
sÈ(YPERGLYCAEMIAÈORÈHYPOGLYCAEMIA
sÈ#ARBONÈDIOXIDE
sÈ)NBORNÈERRORSÈOFÈMETABOLISM
° Porphyria
° Wilson disease
sÈ.UTRITIONALÈDEFICIENCIES
° Vitamin B12 deficiency
° Wernicke encephalopathy
B. Infections
sÈ3EPSIS
sÈ3YSTEMICÈINFECTIONS
sÈ#.3ÈINFECTIONSÈSEEÈBELOW	
C. Neurological
sÈ#.3ÈINFECTIONS
° Encephalitis
° Meningitis
° Brain abscess
sÈ%PILEPSY
° Complex partial seizures
° Non-convulsive status epilepticus
sÈ(EADÈINJURY
sÈ(YPERTENSIVEÈENCEPHALOPATHY
sÈ#ARCINOMATOUSÈMENINGITIS
sÈ0ARANEOPLASTICÈENCEPHALITIS
sÈ,IMBICÈENCEPHALITISÈASSOCIATEDÈWITHÈANTInVOLTAGEÈGATEDÈ
potassium channel antibodies
D. Drugs
sÈ!LCOHOL
RELATED
° Alcohol intoxication
° Alcohol withdrawal
sÈ2ECREATIONALÈDRUGS
° Narcotics
° Cocaine
° Lysergic acid diethylamide (LSD)
° 3,4-methylenedioxymethamphetamine 
(MDMA, ecstasy)
° Phencyclidine
° Ketamine
sÈ0OISONS
° Methanol
° Ethylene glycol
° Insecticides
° Carbon monoxide poisoning
sÈ0RESCRIPTIONÈMEDICATIONS
E. Systemic conditions
sÈ(EPATICÈENCEPHALOPATHY
sÈ2ESPIRATORYÈFAILURE
sÈ2ENALÈFAILURE
sÈ3EVEREÈBURNS
sÈ(YPERTHERMIAÈORÈÈHYPOTHERMIA
F. Psychiatric disease
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DISCUSSION
Hashimoto Encephalopathy
The association of Hashimoto disease with an 
encephalopathy was first described by Lord Brain in 1966 
[3]. Hashimoto encephalopathy (HE) is characterised by an 
encephalopathy with acute or subacute onset, accompanied 
by seizures, tremor, myoclonus, ataxia, psychosis, or stroke-
like episodes, with a relapsing/remitting or progressive 
course. The prevalence is estimated to be 2.1 per 100,000 
[4], although the condition is often under-recognised. 
Women are more commonly affected than men. In a recent 
series, the mean age at onset was 56 years, with the most 
doi:10.1371/journal.pmed.0050186.g001
Figure 1. Electroencephalogram Showing Repetitive Focal Spikes or Sharps Less Than Three per Second 
A. Withdrawal of benzodiazepines, barbiturates, alcohol 
B. Acute structural injury
a. Tumour or cerebral metastases
b. Encephalitis/meningitis
c. Brain abscess
d. Stroke
e. Head injury
f. Subarachnoid haemorrhage/intra-cerebral
haemorrhage/subdural haematoma
g. Cerebral hypoxia
h. Cerebral arteriovenous malformations
i. Posterior reversible encephalopathy syndrome
j. Systemic lupus erythematosus
k. Sagittal sinus thrombosis
C. Metabolic disturbances
a. Hypoglycaemia
b. Hyponatraemia
c. Hypocalcaemia
d. Hypomagnesaemia
e. Hepatic encephalopathy
f. Uraemia
g. Hashimoto encephalopathy
D. Drugs (particularly overdose) and other toxins
a. Theophylline
b. Ciprofloxacin
c. Tricyclic antidepressants
d. Lithium
e. Flumazenil
f. Cyclosporine
g. Lidocaine
h. Metronidazole
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frequent presenting features being tremor, transient aphasia, 
myoclonus, gait ataxia, cognitive impairment, seizures, 
and sleep abnormalities. Misdiagnosis at presentation was 
common, with most cases misdiagnosed as viral encephalitis, 
Creutzfeldt-Jakob disease, dementia, or psychiatric disorders 
[5]. Recurrent seizures are a recognised presentation of this 
condition [6]. Other causes of acute symptomatic seizures 
with multiple seizures upon presentation are listed in Box 2.
Making the Correct Diagnosis
The diagnosis of HE is based on presence of elevated anti-
thyroid antibodies in patients with a compatible clinical 
presentation and exclusion of other causes of encephalopathy 
or acute confusional state (Box 1). Diagnosis requires 
presence of high titres of anti-thyroid peroxidase and/or 
anti-thyroglobulin antibodies, although this is not specific 
and there is no clear correlation between antibody titres and 
the severity of neurological symptoms [7]. The presence of 
anti-thyroid antibodies can sometimes be detected in normal 
individuals, though usually at lower titres. In some cases, 
presence of anti-neuronal antibodies has been noted [8]. 
Most patients have overt or subclinical hypothyroidism at the 
time of presentation, but can also be euthyroid at the time 
of diagnosis. Erythrocyte sedimentation rate and C-reactive 
protein are elevated in some patients [5]. In some aspects, 
Hashimoto encephalopathy resembles a heterogenous group 
of conditions, including Sjögren syndrome and systemic 
lupus erythematosus-associated meningoencephalitis, 
which are characterised by the association with underlying 
autoimmune conditions as well as the unifying feature of 
steroid responsiveness [5,9]. 
CSF analysis is abnormal in around 80% of cases of HE, 
often with elevated protein concentrations, and less often, 
a lymphocytic pleocytosis [7]. MRI is usually normal. Non-
specific EEG abnormalities are often seen in the absence of 
seizures, with slowing of background activity that correlates 
with the clinical severity of the underlying encephalopathy. 
Other EEG findings reported include triphasic waves, 
epileptiform abnormalities, photomyogenic response, and 
photoparoxysmal response. The EEG abnormalities often 
paralleled the clinical course, showing improvement with 
the clinical condition. In one series, myoclonic jerks were 
recorded during the EEG study of about half the patients 
[10]. Patients with sporadic CJD may have clinical features 
identical to that of Hashimoto encephalopathy, when steroid 
responsiveness may be the only differentiating feature [1,9]. 
In addition, diffusion-weighted MRI imaging may also help 
differentiate between the two conditions, with hyper-intense 
abnormalities involving cortex and deep gray matter being 
highly sensitive and specific for sporadic CJD.
Treatment Approach
In addition to supportive measures, use of high-dose 
glucocorticoids is usually associated with marked clinical 
doi:10.1371/journal.pmed.0050186.g002
Figure 2. Electroencephalogram after Combination Anti-Epileptic Therapy with the Focal Spikes Abolished
Ten days after successful treatment, occasional interictal discharges within a normal background were observed.PLoS Medicine  |  www.plosmedicine.org 1347 September 2008  |  Volume 5  |  Issue 9  |  e186
improvement, as well as improvement 
in EEG findings. In a review of 
85 cases, the majority of patients 
who received glucocorticoids 
improved with treatment [11]. 
In some cases, additional short 
courses of glucocorticoids or other 
immunomodulatory therapy may 
be required to treat relapses [5]. 
In more severe cases, intravenous 
immunoglobulins and plasmapheresis 
may also be helpful [12]. Treatment 
of seizures with anti-convulsant 
medications may be necessary as a 
temporary measure, though in some 
cases seizures do not respond to anti-
epileptic drugs but may respond to 
steroid therapy. Thus, considering 
HE in the differential diagnosis is 
of paramount importance. Whilst 
thyroid hormone replacement is 
indicated in patients with biochemical 
evidence of overt hypothyroidism, 
there is no correlation between 
neurological improvement and 
thyroxine replacement. The treatment 
of subclinical hypothyroidism, on the 
other hand, remains controversial 
[13]. 
As illustrated by our case, recognition 
of this form of autoimmune 
encephalopathy and its varied 
presentation is important, as it is readily 
treatable. Presence of a personal or 
family history of thyroid disorder should 
alert clinicians to the possibility of 
Hashimoto encephalopathy in patients 
with an otherwise unexplained subacute 
encephalopathy. Measurements of 
thyroid function and thyroid antibodies 
will be helpful in this setting.
Key Learning Points
Autoimmune thyroid disease may be 
associated with an encephalopathy 
(HE) with acute or subacute onset, 
accompanied by seizures, tremor, 
myoclonus, ataxia, psychosis, or 
stroke-like episodes, with a relapsing/
remitting or progressive course.
A diagnosis of HE should be 
considered in patients with unexplained 
delirium, encephalopathy, or seizures. 
The diagnosis is based on exclusion 
of other causes of delirium, and is 
supported by the finding of elevated 
titres of anti-thyroid antibodies. 
Other autoimmune conditions such 
as Sjögren syndrome and systemic 
lupus erythematosus may also be 
associated with a steroid-responsive 
meningoencephalitis and a similar 
clinical presentation to HE.
Treatment is supportive, though 
use of intravenous glucocorticoids 
is associated with improvement in 
neurological features as well as EEG 
abnormalities.
Thyroid hormone replacement is 
indicated in patients with biochemical 
evidence of overt hypothyroidism, 
though there is no correlation between 
neurological improvement and 
thyroxine replacement.  
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